Stockscreener 앱 받기
0.00
100.00%
-0.833
전일 마감가:
$0.833
열려 있는:
$0
하루 거래량:
0
Relative Volume:
0.00
시가총액:
$3.25M
수익:
$1.92M
순이익/손실:
$-8.81M
주가수익비율:
0.00
EPS:
-15.86
순현금흐름:
$-5.41M
1주 성능:
-100.00%
1개월 성능:
-100.00%
6개월 성능:
-100.00%
1년 성능:
-100.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.00
$0.00
52주 변동 폭
$0.00
$3.50
인보바이오사이언스 Stock (INVO) Company Profile
명칭
Invo Bioscience Inc
전화
(978) 878-9505
주소
5582 BROADCAST COURT, SARASOTA
INVO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
INVO
Invo Bioscience Inc
|
0.00 | 3.25M | 1.92M | -8.81M | -5.41M | -12.34 |
|
ABT
Abbott Laboratories
|
114.23 | 198.13B | 41.22B | 5.77B | 6.49B | 3.29 |
|
SYK
Stryker Corp
|
364.60 | 138.99B | 21.97B | 3.59B | 3.21B | 9.33 |
|
BSX
Boston Scientific Corp
|
88.95 | 131.10B | 15.91B | 1.79B | 1.89B | 1.21 |
|
MDT
Medtronic Plc
|
81.03 | 103.90B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
74.81 | 44.12B | 6.60B | 4.16B | 490.10M | 6.93 |
인보바이오사이언스 주식(INVO)의 최신 뉴스
INVO Bioscience (NASDAQ:INVO) Stock Price Down 4.5% – Here’s What Happened - Defense World
NAYA (NAYA Biosciences) Profitability Rank : 2 (As of Jun. 2024) - GuruFocus.com
INVO Bioscience, Inc. announced that it has received $0.275 million in funding - Marketscreener.com
INVO Bioscience Closes Wisconsin Fertility Institute Acquisition - Marketscreener.com
INVO Bioscience Closes Exclusive U.S. Licensing Agreement with Ferring Pharmaceuticals to Commercialize the Novel Invocell System for Use in the Treatment of Infertility - Marketscreener.com
INVO Bioscience, Inc. Announces Appointment of Pressly Ahammed as Director of International Business Development - Marketscreener.com
INVOcell Appoints Yve Lyppens as Director Business Development Asia Pacific - Marketscreener.com
INVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 - Marketscreener.com
INVO Bioscience, Inc. Announces Grand Opening of "Positib Fertility, an INVO Center" in Monterrey, Mexico on November 1, 2021 - Marketscreener.com
INVO Bioscience Announces the Appointment of Steve Shum as Chief Executive Officer - Marketscreener.com
Top Premarket Gainers - Marketscreener.com
INVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 - Marketscreener.com
INVO Bioscience, Inc. announced that it expects to receive $0.5 million in funding from FirstFire Capital Management LLC - Marketscreener.com
INVO Bioscience changes name, trading symbol after merger - Business Observer
INVO Bioscience confirms name change, new trading symbol following NAYA merger - TipRanks
INVO Bioscience Confirms Corporate Name Change and New Trading Symbol in Connection with Its Recent Merger with NAYA Biosciences - The Manila Times
There is no way INVO Bioscience Inc (INVO) can keep these numbers up - SETE News
B Riley Financial (NASDAQ:RILY) Stock Surges After $386M Deal with Oaktree - DRP Journal
INVO Bioscience (NASDAQ: INVO) Stock Sees Bullish Momentum on Merger News - DRP Journal
INVO Bioscience Completes Merger with NAYA Biosciences - TipRanks
What Happened With Invo BioScience Stock Today? - Benzinga
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com
United States shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com India
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.47% - Investing.com UK
Sarasota fertility company completes merger with bioscience firm - Business Observer
INVO Bioscience merges with NAYA, eyes oncology market - Investing.com
INVO Bioscience and NAYA Biosciences Close Merger, Combined Company to Operate as NAYA Biosciences (NASDAQ: NAYA) - ForexTV.com
Onto Innovation Inc. (NYSE:ONTO) Shares Acquired by Handelsbanken Fonder AB - Defense World
Hoxton Planning & Management LLC Has $276,000 Stake in Target Co. (NYSE:TGT) - Defense World
INVO Bioscience secures $265,000 through Merchant Cash Advance - Investing.com India
INVO Bioscience secures $265,000 through Merchant Cash Advance By Investing.com - Investing.com UK
Research Analysts’ Weekly Ratings Updates for Innoviz Technologies (INVZ) - Defense World
Financial Health Report: Innoviva Inc (INVA)’s Ratios Tell a Tale - The Dwinnex
Interval Partners LP Has $2.52 Million Stock Holdings in Innoviz Technologies Ltd. (NASDAQ:INVZ) - Defense World
Seven Eight Capital LP Sells 17,969 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
Adversity is less terrifying than hope: Innoviz Technologies Ltd (INVZ) - SETE News
Analytical Lens: Exploring Iovance Biotherapeutics Inc (IOVA)’s Financial Story Through Ratios - The Dwinnex
Take off with Invivyd Inc (IVVD): Get ready for trading - SETE News
Inovio Pharmaceuticals Inc Inc. (INO) Price Performance: How to Use Technical Analysis to Make Trading Decisions - The InvestChronicle
Ratio Revelations: Inovio Pharmaceuticals Inc (INO)’s Financial Metrics in the Spotlight - The Dwinnex
Innoviva, Inc.'s (NASDAQ:INVA) Stock Is Going Strong: Have Financials A Role To Play? - Simply Wall St
(INO) Technical Pivots with Risk Controls - Stock Traders Daily
American Century Companies Inc. Purchases 361,797 Shares of Innoviva, Inc. (NASDAQ:INVA) - MarketBeat
InvenTrust Properties Corp. Announces Upsizing and Pricing of Common Stock Offering - StockTitan
Innoviz Technologies (NASDAQ:INVZ) Earns “Overweight” Rating from Cantor Fitzgerald - Defense World
IOVA’s price-to-free cash flow ratio: How it affects investment decisions - US Post News
Innodata Target of Unusually Large Options Trading (NASDAQ:INOD) - Defense World
Incyte Insiders Sold US$4.8m Of Shares Suggesting Hesitancy - Simply Wall St
Itau Unibanco Holding S.A. Acquires New Position in Incyte Co. (NASDAQ:INCY) - Defense World
Pacer Advisors Inc. Buys 2,676,851 Shares of Incyte Co. (NASDAQ:INCY) - Defense World
INVO Bioscience faces Nasdaq delisting over share price - Investing.com India
인보바이오사이언스 (INVO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.54%
자본화:
|
볼륨(24시간):